Literature DB >> 15037156

The pulmonary biology of isoprostanes.

L J Janssen1.   

Abstract

Isoprostanes are widely recognized as useful markers of membrane lipid peroxidation. It seems to be less well appreciated, however, that they also elicit important biological responses, even though this was first shown at the same time that they were introduced as markers of oxidative stress. The past several years have seen the list of cells/tissues which are sensitive to isoprostanes grow considerably: in fact, as we summarize here, there is now evidence that essentially every cell type in the lung responds in some pathologically relevant way to isoprostanes. In this sense, they might well be considered as not just markers of oxidative stress and inflammation, but also as a novel group of inflammatory mediators. Moreover, in addition to their pathological effects, we summarize here the evidence which has led us to hypothesize that isoprostanes could play an important role in vascular smooth muscle physiology as "endothelium-derived hyperpolarizing factors."

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15037156     DOI: 10.1016/j.chemphyslip.2003.10.009

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  4 in total

1.  B1-phytoprostanes trigger plant defense and detoxification responses.

Authors:  Christiane Loeffler; Susanne Berger; Alexandre Guy; Thierry Durand; Gerhard Bringmann; Michael Dreyer; Uta von Rad; Jörg Durner; Martin J Mueller
Journal:  Plant Physiol       Date:  2004-12-23       Impact factor: 8.340

2.  Outdoor air pollution, exhaled 8-isoprostane and current asthma in adults: the EGEA study.

Authors:  Anaïs Havet; Farid Zerimech; Margaux Sanchez; Valérie Siroux; Nicole Le Moual; Bert Brunekreef; Morgane Stempfelet; Nino Künzli; Bénédicte Jacquemin; Régis Matran; Rachel Nadif
Journal:  Eur Respir J       Date:  2018-04-04       Impact factor: 16.671

3.  Identification of potential erythrocyte phospholipid fatty acid biomarkers of advanced lung adenocarcinoma, squamous cell lung carcinoma, and small cell lung cancer.

Authors:  Patricia Sánchez-Rodríguez; Marina C Rodríguez; Jesús Sánchez-Yagüe
Journal:  Tumour Biol       Date:  2015-02-22

Review 4.  Polyunsaturated fatty acids and fatty acid-derived lipid mediators: Recent advances in the understanding of their biosynthesis, structures, and functions.

Authors:  Simon C Dyall; Laurence Balas; Nicolas G Bazan; J Thomas Brenna; Nan Chiang; Felipe da Costa Souza; Jesmond Dalli; Thierry Durand; Jean-Marie Galano; Pamela J Lein; Charles N Serhan; Ameer Y Taha
Journal:  Prog Lipid Res       Date:  2022-05-01       Impact factor: 14.673

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.